The U.S. health regulator put on hold a trial designed to evaluate switching the prescription-only erectile dysfunction drug Cialis to an over-the-counter (OTC) treatment, French drugmaker Sanofi said on Monday.
https://www.pharmalive.com/wp-content/uploads/2022/05/FDA-presses-pause-on-trial-for-OTC-version-of-anti-impotence-drug-Cialis-Reuters-5-30-22.jpg503960Reuters Healthhttps://www.pharmalive.com/wp-content/uploads/2020/01/Pharmalive_4c-300x37.pngReuters Health2022-05-30 12:08:572022-05-31 12:20:07FDA presses pause on trial for OTC version of anti-impotence drug Cialis
